Viewing StudyNCT04658199



Ignite Creation Date: 2024-05-06 @ 3:31 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04658199
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-19
First Post: 2020-12-01

Brief Title: A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Progressive Supranuclear Palsy
Keywords:
Name View
Bepranemab View
Progressive supranuclear palsy View
UCB0107 View
Phase 1B study View
PSP View